MLSS — Milestone Scientific Share News
0.000.00%
- $28.99m
- $27.44m
- $8.97m
Brief: New York Stock Exchange Accepts Milestone Scientific's Plan To Regain Compliance
Brief: Milestone Scientific Signs U.S. Distribution Deal With Clinical Technology
Brief: Milestone Scientific Reports Q2 Loss Per Share Of $0.04
Brief: Milestone Scientific Signs Agreements With Two Additional Independent Distributors For CompuFlo Epidural System
Brief: Milestone Scientific Q1 Loss Per Share $0.06
Brief: Milestone Scientific Reports Q4 Loss Per Share Of $0.06
Brief: Press Release - Milestone Scientific's Compuflo(R) Epidural Instrument Receives License To Sell In Canada
Brief: Milestone Scientific Announces Appointment Of Sharon Smith As Executive Vice President Of Global Sales & Marketing
Brief: Leonard Osser To Re-Assume Role As Ceo Of Milestone Scientific
Brief: Milestone Scientific reports Q3 loss per share $0.04
Brief: Milestone Scientific names Leslie Bernhard as Interim CEO
Brief: Milestone Scientific reports Q2 loss per share $0.05
Brief: Milestone Scientific appoints Daniel Goldberger as CEO
Brief: Milestone Scientific announces 510(K) FDA clearance for compuflo(R) epidural instrument
Brief: Milestone Scientific announces regulatory marketing clearance
Brief: Milestone Scientific reports 10% increase in revenue for fiscal 2016
Brief: Milestone Scientific begins epidural instrument clinical rollout in MENA regions
Brief: Milestone Scientific provides regulatory update regarding epidural instrument
Brief: Milestone Scientific warrants for gross proceeds of $3 mln